The CDC found that hepatitis C cases increased 364% from 2006 to 2012 for residents ages 12-29 in the Appalachian states of Tennessee, Kentucky, West Virginia, and Tennessee. Rural rates were more than double urban rates.
73% of those that responded to a survey regarding risk factors reported they had used intravenous drugs, primarily heroin and prescription opioids.
Add this to the fact that Memphis ranks second in the country for hepatitis C cases per 100,000 population and it is clear Memphis and Tennessee are hot spots for hepatitis c virus and the new drugs that can now cure this disease.
MBGH is working with employers and specialty pharmacy management experts to develop a series of workshops to focus employers on these issues and develop strategies to manage the cost of specialty pharmacy while, at the same time, offering these and other high quality drugs to their employees and dependents.
Look for the announcement of our workshops soon!